Scored 5/10 on whether it helps or hurts everyday people.
FDA to set new rules for nonclinical testing
FDA Modernization Act 3.0
Mixed: some good, some bad ·
If passed, the rule would tell drug makers how to test new medicines without using animals, which could change how quickly drugs reach people.
Our take
What we think, in plain words.
Consumers could see faster drug approvals, but there is a risk that reduced testing might miss safety problems; the bill now lets the FDA decide the details.
Take action
Add your name. At 100 signatures we compile this petition and deliver it to the office — and every signer gets a message to send their own representatives.
0 of 100 in‑district signatures
Step 1 · Pick your position
Step 2 · Add your name
Sign in to oppose this billPicking a side above doesn't sign anything yet — a free account records your name on the petition and keeps it one signature per person. We'll bring you straight back here with your choice saved.
The facts
What the bill actually says, no spin.
- Bill requires the HHS Secretary, through the FDA commissioner, to publish a final rule on nonclinical testing methods.
- The rule would apply to developers of drugs and medical devices.
- The measure has bipartisan sponsors from both parties.
- It has passed the House and is now awaiting Senate action.
In the news
Scanning the news for this bill…
Headlines gathered from across the news, starting points to explore, not endorsements. Always read the official text before acting.
Sources
Read it yourself: the official bill and records.
This bill is in the Federal (Congress) Bill Book 2026
The best and worst Federal (Congress) bills of 2026, one page each — our take on the left, the bill on the right, and room for your notes. No email needed.
Get the free PDF →